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Our understanding of the mechanisms whereby BACE1, the aspartyl protease required for the initial cleavage
of APP to generate amyloid-b (Ab), is regulated in Alzheimer’s disease (AD) remains incomplete. In this issue
of Neuron, O’Connor and coworkers show how energy deprivation, a potential risk factor in AD, triggers
the phosphorylation of the translation initiation factor eIF2a to elevate the translation efficiency of a set of
stress-related transcripts, including that of BACE1, and increases the level of BACE1, thereby accelerating
amyloidogenesis.b-site APP cleaving enzyme 1 (BACE1) is
the rate-limiting enzyme that makes the
initial cleavage of the amyloid-b precursor
protein (APP) and, in concert with g-secre-
tase, gives rise to neurotoxic b-amyloid
peptides (Ab). Ab accumulates in brains of
individuals with Alzheimer’s disease (AD),
and it is believed that Ab plays a central
pathogenic role in this devastating illness
of the elderly. The observations that levels
and activity of BACE1 are increased in
brains of cases of AD (Yang et al., 2003)
led to the idea that chronic increase of
BACE1 in the brain may contribute to the
development of AD. Over the past several
years, concerted efforts have focused
attention on the identification and charac-
terization of molecular mechanisms that
may upregulate the levels of BACE1 in
AD. Altered energy metabolism in the brain
has been considered as a risk factor for AD
(de Leon et al., 2007). Moreover, the finding
that energy metabolism inhibition elevated
the levels of BACE1 and Ab posttranscrip-
tionally strongly supports the view that
energy deprivation could enhance amyloi-
dogenesis in AD (Velliquette et al., 2005).
In this issue of Neuron, O’Connor and
researchers report on a protein translation
mechanism that controls the levels of
BACE1 in the context of energy depriva-
tion that may have direct relevance to
the pathogenesis of AD. To begin to
address how BACE1 is regulated in
response to energy inhibition, O’Connor
and coworkers employed an in vitro
model of energy deficiency. Consistent
with their previous work (Velliquette et al.,
2005), these workers showed first that,using BACE1-expressing cells challenged
with glucose deprivation, the observed
increase of BACE1 was determined to
be consistent with a posttranscriptional
mechanism. Because it is known that
BACE1 protein stability can be influenced
by the lysosomal and ubiquitin-proteaso-
mal degradation pathways (Tesco et al.,
2007), O’Connor and colleagues as-
sessed whether protein stability might
be responsible for the BACE1 upregula-
tion in response to glucose deprivation;
however, pulse-chase studies revealed
that this was not the case. So, what
posttranscription mechanism might be
involved? One clue came from earlier
studies documenting that translation is in-
hibited by the BACE1 mRNA 50 UTR (Lam-
mich et al., 2004; Rogers et al., 2004)
which shares features typical of transla-
tionally regulated stress-responsive
mRNAs. To test the idea that the BACE1
transcript might be a target of transla-
tional control by glucose deprivation,
these investigators examined whether
the 50UTR of BACE1 transcript was
required for the energy-deprivation-
dependent increase of BACE1. Interest-
ingly, results from their mutagenesis
studies showed that the BACE1 mRNA
50 UTR is indeed necessary. Taken
together, these results strongly support
the view that a translation control mecha-
nism is responsible for the energy-depri-
vation-dependent increase of BACE1.
To gain insight into this protein transla-
tion mechanism, these researchers as-
sessed whether levels of BACE1 could be
regulated by specific phosphoproteinsNeuron 60, Dthat are central to stress-induced transla-
tional control pathways given that the
BACE1 mRNA is a member of the family
of translationally regulated stress-res-
ponse transcripts. Intriguingly, in their initial
screen, they identified the a subunit of
eukaryotic translation initiation factor 2
(eIF2a), which is highly phosphorylated at
Ser51 in response to glucose deprivation
and found that selective inhibition of eIF2a
dephosphorylation increases BACE1 level
even in the absence of glucose depriva-
tion. These results indicate that eIF2a is
a key component of the translation initia-
tion complex involved in the energy-depri-
vation-activated BACE1 elevation and that
BACE1 is a translational target of the
stress-induced eIF2a-P (Ser51) pathway.
To further substantiate the important role
of eIF2a in BACE1 translational control,
O’Connor and colleagues showed that
the inhibition of eIF2a phosphorylation
completely prevents the energy-depriva-
tion-induced BACE1 increase.
To uncover the kinase(s) directly res-
ponsible for the phosphorylation of eIF2a,
these researchers screened for the four
known kinases, including PERK and
GCN2, which are respectively activated
by the ER stress and amino acid depri-
vation. Importantly, they were able to
identify PERK as the specific kinase that
phosphorylates eIF2a during glucose
deprivation that governs the translational
efficiency of BACE1 mRNAs. Importantly,
these workers confirmed that such trans-
lational control of BACE1 in response to
energy deprivation also occur in primary
neuronal cultures.ecember 26, 2008 ª2008 Elsevier Inc. 941
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whether this enhanced translational effi-
ciency of BACE1 mRNA impacts on amy-
loidogenesis. To address this, O’Connor
and colleagues took two approaches.
First, they derived neuronal cultures from
a mouse model of amyloidosis (Tg2576
mice) and showed that selective inhibition
of eIF2a dephosphorylation of these
neurons elevated levels of BACE1, as
expected, but importantly led to increased
secretion of Ab. In a second, in vivo
approach, these investigators took
advantage of their previously character-
ized energy-deprivation models (namely,
2-deoxyglucose, a competitive inhibitor
of hexokinase; and 3-nitropropionic acid,
an inhibitor of the Krebs cycle and succi-
nate dehydrogenase) to treat Tg2576
mice with inhibitors of energy metabolism
that resulted in elevation of BACE1 and
Ab (Velliquette et al., 2005). Here, they
showed that chronic energy inhibition in
Tg2576 mice over a period of 3 months
enhanced the phosphorylation of eIF2a
and elevated levels of BACE1 as expected
and, importantly, increased the amyloid
burden in this mouse model. Thus, these
results provide strong support for the
view that chronic energy deprivation
in vivo enhances amyloidogenesis through
a protein translation mechanism involving
phosphorylation of eIF2a that influenced
the translational efficiency of BACE1
mRNA.
Finally, to address the disease relevance
of their findings, O’Connor et al. asked
whether there is a correlation between
eIF2a phosphorylation with the increase
of BACE1 in a mouse model of amyloidosis
and in AD. They first examined levels of
BACE1 and eIF2a in brains of mice that
exhibit extensive amyloid burden (5XFAD
mice; Oakley et al., 2006). Consistent
with their recent findings (Zhao et al.,
2007), they observed that BACE1 levels
in 5XFAD brains were significantly in-
creased. Importantly, levels of phosphory-
lated eIF2a (Ser51) were also increased in
brains of 5XFAD mice. In examining brains
from a cohort of individuals with AD, these
investigators found that BACE1 levels
were significantly increased in brains of
AD cases as previously reported; more-
over, phosphorylation of eIF2a (Ser51)
was concordantly elevated in brains of
these individuals with AD. Together, these
results favor the notion that inappropriate942 Neuron 60, December 26, 2008 ª2008 Ephosphorylation of eIF2a may contribute
to the pathogenesis of AD by increasing
the translation efficiency of BACE1 tran-
scripts.
This novel work of O’Connor et al.
addresses the important question as to
how BACE1 can be upregulated through
translational control via phosphorylation
of eIF2a under a specific pathophysiolog-
ical context and offers a plausible molec-
ular explanation for the upregulation of
BACE1 observed in cases of AD, a propor-
tion of which may be linked to the energy
deprivation associated with this illness.
Importantly, these efforts highlight the
emerging view that the levels of BACE1
can be elevated through multiple ways in
AD and indicate that the molecular mecha-
nisms that govern such upregulation of
BACE1 may be context dependent. This
notion raises the possibility that a variety
of risk factors associated with AD could
converge upon BACE1 and impact on
different pathways that influence the tran-
scriptional, posttranscriptional, transla-
tional, or posttranslational upregulation of
BACE1. Whereas energy deprivation
triggers the phosphorylation of eIF2a to
increase the translation efficiency of
BACE1 mRNA, other mechanisms that
upregulate BACE1 levels may occur under
distinct pathophysiological context. For
example, BACE1 levels can be elevated
in cases of AD through the stabilization of
cyclin-dependent kinase-5 by increased
levels of p25 that activate specific tran-
scription regulators to alter the rate of
BACE1 transcription (Wen et al., 2008).
Alternatively, during apoptosis, caspase-3
cleavage of the adaptor protein GGA3
required for lysosomal degradation of
BACE1 could stabilize BACE1 to increase
Ab generation in AD (Tesco et al., 2007).
Interestingly, noncoding antisense RNA
to BACE1 that is capable of increasing
levels of BACE1 and consequently levels
of Ab through stabilization of BACE1
mRNA, are elevated in cases of AD (Fa-
ghihi et al., 2008). Finally, altered regulation
of microRNAs (Wang et al., 2008; He´bert
et al., 2008) has been shown to correlate
with upregulation of BACE1 in AD.
The extent to which these BACE1 regu-
latory mechanisms, including that de-
scribed by O’Connor and coworkers, con-
tribute to sporadic AD remains to be
clarified. It will be interesting to determine
in the future whether phosphorylation oflsevier Inc.eIF2a is triggered during early stages of
AD or in individuals exhibiting mild cogni-
tive impairment. Additional efforts will be
required to clarify the mechanism whereby
eIF2a phosphorylation controls the dere-
pression of BACE1 mRNA translation in
the future. Their work also raised the
intriguing possibility of additional stress-
related targets that are regulated by phos-
phorylation of eIF2a and whether they too
may contribute to the pathogenesis of
AD. It will be important in future work to
determine whether translation repression
of BACE1 mRNA could be relieved under
various stressful conditions associated
with AD. Nevertheless, if it is true that
the upregulation of BACE1 triggered by
different mechanisms related to various
pathophysiological contexts occurs as an
early step in the pathogenesis of AD, the
work of O’Connor and coworkers would
further emphasize the importance of tar-
geting BACE1 as an anti-amyloid therapy
in efforts to attenuate amyloidogenesis in
AD. The recent discovery that BACE1
also influences neuregulin processing and
neuregulin-ErbB signaling in the nervous
system (Willem et al., 2006; Hu et al.,
2006; Savonenko et al., 2008) raised the
plausibility that pharmacological inhibition
of BACE1 may not be completely free of
mechanism-based toxicity, and future
clinical trials should be alert to potential
untoward side effects associated with this
type of anti-amyloid therapy for AD.
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sliver of the range of temperatures found
throughout the universe. Because of the
strong temperature sensitivity of most
biochemical reactions, it comes as no
surprise that even small temperature vari-
ations within these limits, such as those
associated with gradual climate change,
have profound effects on living organisms.
It is also easy to see the adaptive signifi-
cance of evolved mechanisms that allow
organisms to anticipate changes in envi-
ronmental temperature and adjust to
them. Many animals exhibit differential
activity patterns in warmer versus colder
seasons, hibernation being an extreme
example. Seasonal timekeeping mecha-
nisms that govern these behaviors often
make use of day length as a reliable indi-
cator of the time of year. In this context,
day length is commonly measured by the
coincidence of light and certain phases
of the internal daily time keeping mecha-
nisms of the circadian clock (Dunlap
et al., 2004).
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a molecular mechanism underlying
seasonal adaptive behavior in the fruit fly
Drosophila melanogaster (Majercak et al.,
1999). Cold temperatures induced flies to
show earlier evening-associated loco-
motor activity and a decreased period of
midday rest. This mechanism is proposed
to be seasonally adaptive because it
allows flies to avoid midday activity during
hot spring and summer days when there
may be a risk of desiccation, while allow-
ing midday activity during colder fall and
winter days when it may be advantageous.
Temperature-dependent mRNA splicing
of dmpi8 the terminal intron in the circa-
dian clock gene period (per) was shown
to make a substantial contribution to this
response by affecting the phase of accu-
mulation of both per transcript and PER
protein. The fact that per forms the entry
point for seasonal modulation of circadian
timing is consistent with its central role in
the circadian clock circuits. In the
Drosophila circadian clock, per is one of
the transcriptional targets for CLOCK/
CYCLE (CLK/CYC), a heterodimeric
complex of two bHLH (basic helix-loop-
helix) PAS (PER-ARNT-SIM) transcription
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factors that activates expression at dusk.
PER protein accumulates with a substan-
tial delay relative to per transcript, in part
because it is destabilized by phosphoryla-
tion events that promote its degradation
through the ubiquitin-proteosome
pathway. The accumulation of TIMELESS
(TIM) protein, the product of another CLK/
CYC regulated gene, is necessary to
stabilize PER in a complex that also
includes the kinase DOUBLETIME (DBT)
and to mediate nuclear transfer around
midnight. TIM itself is subject to light-
dependent degradation, allowing the
clock circuits to be synchronized to envi-
ronmental light/dark signals. Once in the
nucleus, PER directly interacts with CLK/
CYC and inhibits promoter binding, thus,
providing negative feedback on the tran-
scription ofper, tim, and other coregulated
genes (see Figure 1; Dubruille and Emery,
2008; Hardin, 2005; Stanewsky, 2003;
Wijnen and Young, 2006).
The status of per as a dosage-depen-
dent regulator of circadian time keeping
was established in early studies exam-
ining the relationship between per gene
dosage and period length. Mutant alleles
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